Tirzepatide 40mg

Tirzepatide 40mg – Dual GLP-1/GIP Receptor Agonist Research Peptide

Tirzepatide is a next-generation, dual-incretin research peptide that activates both the GLP-1 and GIP receptors. This dual mechanism has made it one of the most studied compounds in metabolic, glycemic-control, and appetite-regulation research. Each Kynetide vial contains 40mg of Tirzepatide Acetate (CAS 2023788-19-2), third-party HPLC tested to 99.3% purity and supplied with a full Certificate of Analysis and batch traceability.

Why Researchers Choose Kynetide Tirzepatide

• Verified 99.3% HPLC purity — exceeds the 98% research-grade standard
• Mass spectrometry confirmed at 4810.2 Da
• Peptide content 89.4%, water content 3.5% (KF), endotoxins within limits
• USA lab tested with full residual-solvent and endotoxin profiling
• Ships with a batch-specific COA (Batch TIR-26040901) for full reproducibility

Research Applications

As a dual GLP-1/GIP agonist with a PEGylated fatty-acid side chain for extended duration, Tirzepatide is investigated in preclinical models for its synergistic effects on glycemic control, insulin sensitivity, appetite signaling, and energy expenditure. It is a frequent reference compound for next-generation incretin and metabolic-syndrome research alongside semaglutide and retatrutide.

Specifications

• Compound: Tirzepatide Acetate
• Quantity: 40mg per vial
• CAS No.: 2023788-19-2
• Purity: 99.3% (HPLC)
• Form: White lyophilized powder
• Storage: Refrigerate 2–8°C, do not freeze; protect from light

Research Use Only. This product is supplied strictly for in-vitro and laboratory research use only. It is not a drug, supplement, or cosmetic, and is not intended for human or veterinary use, diagnostic, or therapeutic purposes.

Certificate of Analysis (COA) — Tirzepatide

Batch No: TIR-26040901 | CAS No.: 2023788-19-2 | Mfg Date: Apr 09, 2026 | Retest Date: Apr 09, 2028

Product: Tirzepatide Acetate | Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈ | Dual GLP-1 / GIP receptor agonist

★ Verified HPLC Purity: 99.3% — Exceeds NLT 98.0% requirement. Third-party tested • HPLC verified • Full batch traceability.

Storage: Short Term 2–8°C | Long Term below -10°C, protected from light.

Tirzepatide peptide COA 99.3% purity — third-party tested dual GLP-1/GIP receptor agonist. Mass spec confirmed at 4810.2 Da with full water-content and endotoxin compliance. Researchers studying next-generation incretin mechanisms, metabolic regulation, or glycemic-control models will value this complete analytical and batch-traceability package. For research and educational use only — not for human consumption.